Showing results (251-260 of 304) with videos related to

Sort By:
Pageof 31
European Journal of Cancer (Oxford, England : 1990)|July 8, 2020
Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trialBenedetta Conte, Marco Bruzzone, Matteo Lambertini, et al.
Critical Reviews in Oncology/Hematology|May 8, 2024
Unlocking the potential of Molecular Tumor Boards: from cutting-edge data interpretation to innovative clinical pathwaysBrenno Pastò, Giulia Buzzatti, Clorinda Schettino, et al.
The Journal of Pathology|October 25, 2024
A comprehensive luminal breast cancer patient-derived xenografts (PDX) library to capture tumor heterogeneity and explore the mechanisms of resistance to CDK4/6 inhibitorsIlenia Segatto, Maria Chiara Mattevi, Gian Luca Rampioni Vinciguerra, et al.
Journal of the National Cancer Institute|May 15, 2020
Overall Survival of CDK4/6-Inhibitor-Based Treatments in Clinically Relevant Subgroups of Metastatic Breast Cancer: Systematic Review and Meta-AnalysisFrancesco Schettini, Fabiola Giudici, Mario Giuliano, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2023
Serum thymidine kinase activity in patients with HR-positive/HER2-negative advanced breast cancer treated with ribociclib plus letrozole: Results from the prospective BioItaLEE trialLuca Malorni, Giampaolo Bianchini, Roberta Caputo, et al.
Clinical Breast Cancer|June 18, 2019
The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast CancerStefania Gori, Fabio Puglisi, Stefano Moroso, et al.
NPJ Breast Cancer|June 8, 2023
Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancerLuca Licata, Giulia Viale, Mario Giuliano, et al.
JCO Precision Oncology|May 4, 2023
Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker AnalysisLorenzo Gerratana, Andrew A Davis, Marko Velimirovic, et al.
European Journal of Cancer (Oxford, England : 1990)|December 13, 2016
Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studiesMatteo Lambertini, Marcello Ceppi, Francesco Cognetti, et al.
Journal of Cachexia, Sarcopenia and Muscle|February 6, 2019
The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patientsDebora Basile, Annamaria Parnofiello, Maria Grazia Vitale, et al.
Pageof 31